Pyridam Farma Tbk vs Summarecon Agung Tbk. — how do they compare? Pyridam Farma Tbk trades at Rp214 (market cap 2.31T, 10.47M 24h volume), while Summarecon Agung Tbk. trades at Rp322 (market cap 5.05T, 29.26M 24h volume). The key difference: Summarecon Agung Tbk. is far larger — about 2.2× Pyridam Farma Tbk's market cap, and Summarecon Agung Tbk. is more actively traded (29.26M versus 10.47M). Which is the better fit depends on your goals.
| PYFA | SMRA | |
|---|---|---|
Market Cap | 2.31T | 5.05T |
Volume | 10.47M | 29.26M |
Lot | 104.73K | 292.59K |
Turnover | 2.2B | 9.3B |
Average Price | 209.71 | 317.73 |
Value | 2.2B | 9.3B |
Indicative Equilibrium Price | 214 | 322 |
Indicative Equilibrium Volume | 10.89K | 3.02K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Pyridam Farma Tbk. Founded in Jakarta based on Limited Company Act on November 27th 1976 and start the commercial operation since 1978 which conduct in pharmaceutical business.On its first establishmnent, the corporate produce & distribute medicine products for livestock & pet.. Since 1985 the corporate develop pharmacy division which emphasize produce and distribute health product for human and for livestock held by veterinary division.
Read more on PYFA →PT Summarecon Agung Tbk (the Company) was established within the framework of the Domestic Capital Investment Law based on notarial deed No. 308 dated November 26, 1975 of Ridwan Suselo, S.H. PT. Summarecon Agung Tbk is one of the nation`s leading township developers. Entering its twenty-forth year, the original 10-hectare landbank it started with has turned into a vibrant, 500 hectare township in North Jakarta where commercial vivacity peacefully coexists with its houses numbering in the tens of thousands.
Read more on SMRA →